Pulmonary Sarcoidosis Pipeline

LAS VEGAS, NV, UNITED STATES, January 22, 2025 /EINPresswire.com/ -- DelveInsight’s, “Pulmonary Sarcoidosis Pipeline Insight” report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Pulmonary Sarcoidosis pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.

Discover the latest drugs and treatment options in the Pulmonary Sarcoidosis Pipeline. Dive into DelveInsight's comprehensive report today! @ Pulmonary Sarcoidosis Pipeline Outlook

Key Takeaways from the Pulmonary Sarcoidosis Pipeline Report
• In January 2025:- Bristol-Myers Squibb- The purpose of this study is to evaluate the efficacy, safety, and tolerability of BMS-986278 in Participants with Progressive Pulmonary Fibrosis.
• DelveInsight’s Pulmonary Sarcoidosis pipeline report depicts a robust space with 10+ active players working to develop 10+ pipeline therapies for Pulmonary Sarcoidosis treatment.
• The leading Pulmonary Sarcoidosis Companies such as Novartis, aTyr Pharma, Relief Therapeutics, AI Therapeutics, SarcoMed USA, and others.
• Promising Pulmonary Sarcoidosis Therapies such as BMS-986278, Inhaled Treprostinil, Namilumab, and others

Stay ahead with the most recent pipeline outlook for Pulmonary Sarcoidosis. Get insights into clinical trials, emerging therapies, and leading companies with DelveInsight @ Pulmonary Sarcoidosis Treatment Drugs

Pulmonary Sarcoidosis Emerging Drugs

• CMK 389: Novartis
CMK 389 acts as inhibitors of Interleukin 18. It is being developed by Novartis for Pulmonary sarcoidosis and is currently in phase II stage of development.

• ATYR1923: aTyr Pharma
ATYR1923 is a potential first-in-class, disease modifying therapy for patients with severe inflammatory lung diseases with high unmet medical need. ATYR1923 works by selectively modulating Neuropilin-2 (NRP2) to downregulate the innate and adaptive immune responses in uncontrolled inflammatory disease states to resolve inflammation and prevent subsequent fibrosis. ATYR1923 is conducting a Phase 1b/2a clinical trial in pulmonary sarcoidosis, a major form of interstitial lung disease (ILD), a group of immune-mediated disorders that cause progressive fibrosis of the lung.

Explore groundbreaking therapies and clinical trials in the Pulmonary Sarcoidosis Pipeline. Access DelveInsight's detailed report now! @ New Pulmonary Sarcoidosis Drugs

Pulmonary Sarcoidosis Companies
Novartis, aTyr Pharma, Relief Therapeutics, AI Therapeutics, SarcoMed USA, and others.

Pulmonary Sarcoidosis pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration
• Infusion
• Intradermal
• Intramuscular
• Intranasal
• Intravaginal
• Oral
• Parenteral
• Subcutaneous
• Topical
• Molecule Type

Pulmonary Sarcoidosis Products have been categorized under various Molecule types such as
• Vaccines
• Monoclonal Antibody
• Peptides
• Polymer
• Small molecule
• Product Type

Unveil the future of Pulmonary Sarcoidosis Treatment. Learn about new drugs, pipeline developments, and key companies with DelveInsight's expert analysis @ Pulmonary Sarcoidosis Market Drivers and Barriers- https://www.delveinsight.com/sample-request/pulmonary-sarcoidosis-pipeline-insight?utm_source=einpresswire&utm_medium=pressrelease&utm_campaign=ypr

Scope of the Pulmonary Sarcoidosis Pipeline Report
• Coverage- Global
• Pulmonary Sarcoidosis Companies- Novartis, aTyr Pharma, Relief Therapeutics, AI Therapeutics, SarcoMed USA, and others.
• Pulmonary Sarcoidosis Therapies- BMS-986278, Inhaled Treprostinil, Namilumab, and others.
• Pulmonary Sarcoidosis Therapeutic Assessment by Product Type: Mono, Combination, Mono/Combination
• Pulmonary Sarcoidosis Therapeutic Assessment by Clinical Stages: Discovery, Pre-clinical, Phase I, Phase II, Phase III

Get the latest on Pulmonary Sarcoidosis Therapies and clinical trials. Download DelveInsight's in-depth pipeline report today! @ Pulmonary Sarcoidosis Companies, Key Products and Unmet Needs- https://www.delveinsight.com/sample-request/pulmonary-sarcoidosis-pipeline-insight?utm_source=einpresswire&utm_medium=pressrelease&utm_campaign=ypr

Table of Content
1. Introduction
2. Executive Summary
3. Pulmonary Sarcoidosis: Overview
4. Pipeline Therapeutics
5. Therapeutic Assessment
6. Pulmonary Sarcoidosis– DelveInsight’s Analytical Perspective
7. In-depth Commercial Assessment
8. Pulmonary Sarcoidosis Collaboration Deals
9. Late Stage Products (Phase III)
10. Drug Name: Company Name
11. Drug profiles in the detailed report…..
12. Mid Stage Products (Phase II)
13. CMK389: Novartis
14. Drug profiles in the detailed report…..
15. Early Stage Products (Phase I/II)
16. ATYR1923: aTyr Pharma
17. Drug profiles in the detailed report…..
18. Early Stage Products (Phase I)
19. LAM–001: AI Therapeutics
20. Drug profiles in the detailed report…..
21. Inactive Products
22. Pulmonary Sarcoidosis Key Companies
23. Pulmonary Sarcoidosis Key Products
24. Pulmonary Sarcoidosis- Unmet Needs
25. Pulmonary Sarcoidosis- Market Drivers and Barriers
26. Pulmonary Sarcoidosis- Future Perspectives and Conclusion
27. Pulmonary Sarcoidosis Analyst Views
28. Pulmonary Sarcoidosis Key Companies
29. Appendix

List of Top Selling Market Research Reports in 2025

Varicose Vein Treatment Devices Market - https://www.delveinsight.com/report-store/varicose-vein-treatment-devices-market
Vascular Access Devices Market - https://www.delveinsight.com/report-store/vascular-access-device-market
Indwelling Catheters Market - https://www.delveinsight.com/report-store/indwelling-catheters-market
Healthcare Competitive Benchmarking - https://www.delveinsight.com/consulting/competitive-benchmarking-services
Lymphoedema Market - https://www.delveinsight.com/report-store/lymphoedema-market
Pacemakers Market - https://www.delveinsight.com/report-store/pacemakers-market
Myeloproliferative Neoplasms Market - https://www.delveinsight.com/report-store/myeloproliferative-neoplasms-market
Surgical Mask & Respirator Market - https://www.delveinsight.com/report-store/surgical-mask-respirator-market
Nk Cell Therapy Market - https://www.delveinsight.com/report-store/nk-cell-therapy-market
Novel Drug Delivery Devices Market - https://www.delveinsight.com/report-store/novel-drug-delivery-devices
Testicular Neoplasm Market - https://www.delveinsight.com/report-store/testicular-cancer-pipeline-insight
Phototherapies For Psoriasis Market - https://www.delveinsight.com/report-store/chronic-plaque-psoriasis-market
Skin Neoplasm Market - https://www.delveinsight.com/report-store/nonmelanoma-skin-cancer-market
Microscopy Device Market - https://www.delveinsight.com/report-store/microscopy-device-market
Bone Growth Stimulator Market - https://www.delveinsight.com/report-store/bone-growth-stimulators-market
Urea Cycle Disorders Market - https://www.delveinsight.com/report-store/urea-cycle-disorders-market
Antibody Drug Conjugate Market - https://www.delveinsight.com/report-store/antibody-drug-conjugate-market
Total Knee Arthroplasty Market - https://www.delveinsight.com/report-store/total-knee-arthroplasty-market
Cardiac Implantable Electronic Devices Market - https://www.delveinsight.com/report-store/cardiac-implantable-electronic-devices-cieds-market
Dyspepsia Market - https://www.delveinsight.com/report-store/functional-dyspepsia-epidemiology-forecast-insight
Lactose Intolerance Market - https://www.delveinsight.com/report-store/lactose-intolerance-market
Medical Marijuana Market - https://www.delveinsight.com/report-store/medical-marijuana-market-insight
Asperger Syndrome Market - https://www.delveinsight.com/report-store/autism-spectrum-disorder-asd-market
Catheter Stabilization Devices Market - https://www.delveinsight.com/report-store/catheter-stabilization-securement-device-market

About Us

DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.

Yash Bhardwaj
DelveInsight
+91 9650213330
email us here

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.